The global chronic hepatitis B treatment market is witnessing significant expansion. This trend can be connected to a number of factors, including an increasing population, enhanced diagnostic capabilities, and escalating awareness about the disease. The market is in addition driven by advancements in treatment approaches, such as antiviral medicat